Brant Inman, MD, surgical oncologist, urologic oncologist, Duke Cancer Center, discusses novel immunotherapy combinations for patients with bladder cancer.
Brant Inman, MD
Advertisement
Articles by Brant Inman, MD
Brant Inman, MD, surgical oncologist, urologic oncologist, Duke Cancer Center discusses biomarkers for immunotherapy in patients with bladder cancer.
Brant Inman, MD, surgical oncologist, urologic oncologist, Duke Cancer Center, discusses the role of chemotherapy in bladder cancer.
Brant Inman, MD, surgical oncologist, urologic oncologist, Duke Cancer Center, discusses the biology of bladder cancer.
Advertisement
Latest Updated Articles
Dr. Inman Discusses the Biology of Bladder CancerPublished: October 3rd 2017 | Updated:
Dr. Inman Discusses the Role of Chemotherapy in Bladder CancerPublished: October 13th 2017 | Updated:
Dr. Inman on Biomarkers for Immunotherapy in Bladder CancerPublished: November 10th 2017 | Updated:
Dr. Inman on Immunotherapy Combinations in Bladder CancerPublished: November 21st 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
The OncFive: Top Oncology Articles for the Week of 1/25
3
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
4
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
5